20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Therapeutic dendrimer
#5402Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
#5403Dosage Regimens of Lingo-1 Antagonists and Uses for Treatment of Demyelinating Disorders
#5404Polypeptides and medical uses thereof
#5405Compositions and methods for diagnosing and/or treating kidney injury
#5406METHOD TO PRODUCE AN IMMUNOGLOBULIN PREPARATION WITH IMPROVED YIELD
#5407Tryptamine prodrugs
#5408METHODS AND COMPOSITIONS FOR TARGETING T-CELL CANCERS
#5409METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-VEGF ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE
#5410METHODS OF TREATING DISEASES RELATED TO NET FORMATION WITH PARENTERAL ADMINISTRATION OF POLYSIALYLATED DNASE I
#5411Dosing regimens and related compositions and methods
#5412TREATING INFLAMMATION USING LLP2A-BISPHOSPHONATE CONJUGATES AND MESENCHYMAL STEM CELLS
#5413Compositions comprising a norovirus nucleic acid and methods of use thereof
#5414Multivalent pneumococcal polysaccharide-protein conjugate composition
#5415Method of treating AML subtypes using arginine-depleting agents
#5416MRNA therapy for pompe disease
#5417COMPOSITION AND METHODS FOR REGULATING CHONDROCYTE PROLIFERATION AND INCREASING OF CARTILAGE MATRIX PRODUCTION
#5418Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid
#5419Satiation peptide administration
#5420Treatment of tobacco addiction by a tobacco leaf extract
#5421Treatment of warts
#5422EXPRESSION VECTOR, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING THE SAME
#5423Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
#5424MICROSPHERE-BASED DELIVERY AND EX VIVO MANIPULATION OF DENDRITIC CELLS FOR AUTOIMMUNE THERAPIES
#5425Pharmaceutical composition and use thereof
#5426ANTIVIRAL THERAPY
#5427[6R]-MTHF - an efficient folate alternative in 5-fluorouracil based chemotherapy
#5428METHODS, PARENTERAL PHARMACEUTICAL FORMULATIONS, AND DEVICES FOR THE PREVENTION OF OPIOID OVERDOSE
#5429Parenteral Formulations of Dopamine Agonists
#5430Methods of treating cancer
#5431Use of carbamate compound for preventing, alleviating or treating myotonia
#5432Methods for decreasing injuries associated with intraoperative hypotension
#5433A LIQUID INJECTABLE COMPOSITION
#5434Composition and methods for stimulating clearance of amyloid-beta protein
#5435Hydrolyzed Pea Protein-Based Nutrient Composition
#5436COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISEASES
#5437GATA3 inhibitors for the promotion of subcutaneous fat deposition
#5438METHODS AND COMPOSITIONS FOR TREATMENT OF FRONTOTEMPORAL DEMENTIA
#5439Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies
#5440Mitogen-activated protein kinase kinase (MEK) degradation compounds and methods of use
#5441ROSMARINIC ACID DERIVATIVE, ROSMARINIC ACID-DERIVED PARTICLES, COMPOSITION CONTAINING SAME FOR TREATING INFLAMMATORY DISEASE
#5442Imaging of metastatic or recurrent cancer
#5443AXL-SPECIFIC ANTIBODIES FOR TREATMENT OF NON-SMALL CELL LUNG CANCER
#5444INJECTABLE CANNABINOID FORMULATIONS FOR TREATING PAIN
#5445AQUEOUS PHARMACEUTICAL FORMULATIONS
#5446VEGF Antagonist Formulations
#5447Recombinant Modified Vaccinia Virus Ankara (MVA) Foot and Mouth Disease Virus (FMDV) Vaccine
#5448BOTULINUM TOXIN ADMINISTRATION FOR TREATMENT OF NEUROGENIC DETRUSOR OVERACTIVITY ASSOCIATED URINARY INCONTINENCE
#5449NOVEL USES OF BOTULINUM NEUROTOXIN FOR TREATING LIPOEDEMA
#5450REGENERATIVE ABSCOPAL EFFECTS
#5451FORMULATION COMPRISING OZONISED OIL IN THE TREATMENT OF A TUMOUR
#5452BI-FUNCTIONAL CO-POLYMER USE FOR OPHTHALMIC AND OTHER TOPICAL AND LOCAL APPLICATIONS
#5453LOW-INTENSITY TREATMENT OF HEMATOLOGICAL DISORDERS
#5454THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING ACUTE MYELOID LEUKEMIA USING DEVIMISTAT
#5455Small molecule-mediated restoration of airway surface physiology in human cystic fibrosis lung epithelia
#5456Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)
#5457Methods of Treatment of Cancer Comprising CDC7 Inhibitors
#5458BUPRENORPHINE TO TREAT RESPIRATORY DEPRESSION
#5459FORMULATIONS OF BENDAMUSTINE
#5460READY TO USE INTRAVENOUS INFUSION OF BRIVARACETAM OR SALT THEREOF
#5461Taxane Particles and Their Use
#5462Methods of using probenecid for treatment of coronavirus infections
#5463Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
#5464SILICA-BASED DRUG NANOCAPSULES
#5465Perineural administration of resiniferatoxin for treatment of maladaptive pain
#5466DOCETAXEL COMPOSITION FOR INJECTION AND PREPARATION METHOD THEREFOR
#5467Cas-ready mouse embryonic stem cells and mice and uses thereof
#5468Dosages and methods for delivering lipid formulated nucleic acid molecules
#5469INTRALESIONAL ADMINISTRATION OF PD-1 INHIBITORS FOR TREATING SKIN CANCER
#5470Cartilage replacement compositions and methods
#5471Morphic forms of trilaciclib and methods of manufacture thereof
#5472Methods of treating pain
#5473METHOD OF TREATING A LOCALIZED FIBROTIC DISORDER USING A TNF RECEPTOR 2 ANTAGONIST
#5474NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE
#5475Subcutaneous Delivery of Adenovirus with Dual Targeting
#5476Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria
#5477Pharmaceutical Compositions And Methods
#5478RAPID ACTION INSULIN FORMULATIONS AND PHARMACEUTICAL DELIVERY SYSTEMS
#5479COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING HUMAN GLUCAGON AND A CO-POLYAMINO ACID
#5480Pharmaceutical composition for preventing and treating glaucoma, containing adenosine derivative
#5481Compositions and methods for the treatment of peripheral artery disease and cardiopulmonary diseases
#5482METHODS OF ADMINISTERING INTRAVENOUS MELOXICAM PRE-OPERATIVELY AND IN COMBINATION WITH OTHER DRUGS
#5483METHODS FOR TREATING SCHIZOPHRENIA
#5484Therapeutic drug for dyskinesia
#5485Compositions and methods for intrathecal administration of MCOPPB for pain relief
#5486Liquid ready-to-use formulation of levothyroxine
#5487Devices, agents, and associated methods for selective modulation of renal nerves
#5488Temperature-based transient delivery of nucleic acids and proteins to cells and tissues
#5489Anti-angiogenic miRNA therapeutics for inhibiting corneal neovascularization
#5490Therapeutic dendrimer
#5491Methods of Treating Rheumatoid Arthritis
#5492SYNTHETIC HEME-CONTAINING MOLECULES AND THEIR USE
#5493Adeno-associated virus variant capsids and methods of use thereof
#5494COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE
#5495STORAGE CASE FOR MUSICAL ACCESSORIES
#5496METHODS FOR THE TREATMENT OF DANON DISEASE AND OTHER DISORDERS OF AUTOPHAGY
#5497ADDITIVES FOR PROTEIN FORMULATIONS TO IMPROVE THERMAL STABILITY
#5498EXCIPIENT COMPOUNDS FOR PROTEIN PROCESSING
#5499Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#5500Zonal and targeted methods and uses for treating a migraine disorder
#5501Pharmaceutical liquid composition of botulinum toxin with improved stability
#5502Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#5503Pharmaceutical composition and use
#5504Methods of treatment
#5505PHARMACEUTICAL COMPOSITIONS FOR INTRAVENOUS INFUSION IN PLASTIC BAGS WITH REDUCED ADSORPTION ON BAG MEMBRANE
#5506TREATMENT OF DEPRESSIVE DISORDERS
#5507METHOD FOR PREPARING AND DELIVERING BISANTRENE FORMULATIONS
#5508COMPOUNDS FOR THE TREATMENT OF MALARIA
#5509PHARMACEUTICAL COMPOSITIONS AND METHODS
#5510INJECTABLE MELPHALAN COMPOSITIONS COMPRISING A CYCLODEXTRIN DERIVATIVE AND METHODS OF MAKING AND USING THE SAME
#5511Phytonadione compositions and related methods
#5512Reduction of adipose tissue
#5513Neuroprotective liposome compositions and methods for treatment of stroke
#5514LEVODOPA INFUSION SOLUTION
#5515Methods for Treating TNFa-Related Diseases
#5516TGF- RECEPTOR II ISOFORM, FUSION PEPTIDE, METHODS OF TREATMENT AND METHODS IN VITRO
#5517COMPOSITIONS AND METHODS FOR DELIVERY OF AAV
#5518Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors
#5519BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
#5520Delivery device
#5521ANTIBODY FORMULATION
#5522Methods of using HSV-2 single cycle virus delta-gD and HSV-2 recombinant glycoprotein D
#5523NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#5524COMPOSITIONS OF EXENDIN-4 DERIVATIVES
#5525MODULATING RESPONSES TO CHECKPOINT INHIBITOR THERAPY
#5526Ultrasound-guided rete testis injection/aspiration device
#5527TREATMENT OR PREVENTION OF ANAEMIA IN PREGNANT NON-HUMAN MAMMALS
#5528COMPOUNDS AND METHODS OF THEIR USE
#5529Accelerated treatment of COVID-19 and SAR's type viruses
#5530Prevention and Treatment of Osteoarthritis by Inhibition of Insulin Growth Factor-1 Signaling
#5531Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses
#5532Storage stable aqueous injectable solution comprising diclofenac
#5533PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF ISCHEMIC CARDIOVASCULAR DISEASE
#5534PARENTERAL DELIVERY OF AVIZAFONE
#5535Injectable formulations of anesthetics for any pathological pain
#5536SLURRY AND SOLUTION COMPOSITIONS
#5537Pharmaceutical compositions for parenteral administration comprising ibuprofen and a phosphate buffer
#5538READY-TO-USE INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING NEOSTIGMINE AND GLYCOPYRROLATE
#5539Fusion proteins comprising extracellular domain of human CD22
#5540Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody
#5541Methods of treating ocular disorders by administering a VEGF-binding antibody covalently linked to a hyaluronic acid polymer
#5542HIGH DOSE TREATMENTS FOR ALZHEIMER'S DISEASE
#5543NOVEL ANTIBODIES SPECIFICALLY BINDING TO ZIKA VIRUS EPITOPES AND USES THEREOF
#5544COMBINATION THERAPY OF PEPTIDOMIMETIC MACROCYCLES
#5545Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostic and therapeutic delivery
#5546Guiding Musculoskeletal Procedures
#5547Biodegradable, thermally responsive injectable hydrogel for treatment of ischemic cardiomyopathy
#5548Methods for treating and diagnosing blinding eye diseases
#5549PHARMACEUTICAL PRODRUGS AND METHODS OF THEIR PREPARATION AND USE
#5550Shear-thinning compositions as an intravascular embolic agent
#5551Recombinant thrombomodulin domain 1 for use in treating eye diseases associated with pathological ocular angiogenesis
#5552C-terminal fragment of tetanus toxin (Hc) for treatment of depression
#5553Vista antagonist and methods of use
#5554BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTIONS
#5555METHODS OF TREATING CEREBRAL PALSY AND HYPOXIC-ISCHEMIC ENCEPHALOPATHY USING HUMAN UMBILICAL CORD TISSUE-DERIVED MESENCHYMAL STROMAL CELLS
#5556Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#5557Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#5558Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
#5559Compositions and methods for treating transthyretin (TTR) mediated amyloidosis
#5560System and method for diagnosis and treatment
#5561Methods and formulations for modulating Lyn kinase activity and treating related disorders
#5562STORAGE-STABLE READY-TO-USE INJECTABLE FORMULATIONS OF TRABECTEDIN
#5563SOLID COMPOSITIONS OF ACTIVES, PROCESSES FOR PREPARING SAME AND USES OF SUCH SOLID COMPOSITIONS
#5564THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#5565Isoflavonoid compositions and methods for the treatment of cancer
#5566CARMUSTINE FORMULATION
#5567Phytonadione compositions and related methods
#5568Storage stable sincalide formulations
#5569MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION
#5570COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
#5571Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)
#5572Antibodies specifically binding to Zika virus epitopes and uses thereof
#5573DENDRIMER-BIOADHESIVE POLYMER HYDROGEL NANOGLUE AND USE THEREOF
#5574Ascorbate formulations and methods of use as contrast agents
#5575IMMUNOADSORPTION
#5576Method and composition for treating neuropathic pain
#5577Compositions and Methods for Treating Dopamine Disorders
#5578Delivery of Urea to Cells of the Macula and Retina Using Liposome Constructs
#5579Methods of treating severe inflammation
#5580Compositions and methods for stabilizing protein-containing formulations
#5581Reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibition
#5582Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
#5583PHOSPHOSERINE CONTAINING COMPOSITIONS FOR IMMUNE TOLERANCE INDUCTION
#5584PHARMACEUTICAL PRODUCT FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE
#5585Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#5586Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration
#5587Joint cavity injection preparation and use thereof
#5588INJECTABLE FORMULATIONS FOR TREATING CANCER
#5589Methods of reducing risk of preterm birth
#5590CROSS-LINKED SUPRAMOLECULAR NANOPARTICLES FOR CONTROLLED RELEASE OF ANTIFUNGAL DRUGS AND STEROIDS - A NEW THERAPEUTIC APPROACH FOR ONYCHOMYCOSIS AND KELOID
#5591Methods of treating rheumatic diseases using trimetazidine-based compounds
#5592Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
#5593Methods and Compositions for Administering an Active Agent to the Pleura of a Patient
#5594STABLE AQUEOUS INJECTABLE SOLUTION OF EPINEPHRINE
#5595ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#5596Compositions and methods for inhibiting expression of the LECT2 gene
#5597COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC HEART DISEASE
#5598MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS
#5599MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERS
#5600Stable liquid pharmaceutical formulation of anti-influenza virus antibody
#5601Therapeutic uses of fibrinogen gamma prime variants
#5602ANTIGENIC PEPTIDES AND USES THEREOF FOR DIAGNOSING AND TREATING AUTISM
#5603Amino acid derivative of glucosamine stimulating extracellular matrix synthesis and pharmaceutical composition comprising the same
#5604Pentaaza macrocyclic ring complexes possessing oral bioavailability
#5605METHOXYCHALCONE DERIVATIVES AND USES THEREOF
#5606PRODRUG OF ITRACONAZOLE AND USES THEREOF
#5607Animal protein-free pharmaceutical compositions
#5608Nanoparticle delivery system for targeted anti-obesity treatment
#5609NOVEL TREATMENT OF DYSPHAGIA
#5610COMPOSITION FOR INJECTION WHICH CAN BE USED FOR TREATMENT OF HEART DISEASES AND CONTAINS FIBROBLASTS, AND METHOD FOR PRODUCING FIBROBLAST FOR THERAPY USE
#5611DOXYCYCLINE INJECTION FOR SCLEROTHERAPY OF LOWER EYELID FESTOONS AND MALAR EDEMA
#5612FULVESTRANT FORMULATIONS AND METHODS OF THEIR USE
#5613TREATMENT OF SKIN DISORDERS WITH COMPOSITIONS COMPRISING AN EGFR INHIBITOR
#5614ANTIBIOTIC SOLUTION AND METHOD OF INJECTION TO PREVENT OPHTHALMIC INFECTIONS
#5615ANTICANCER ROCAGLAMIDE DERIVATIVES
#5616Methods of using nitric oxide donor compounds for treatment of COVID-19 and other infectious diseases
#5617TCA CYCLE INTERMEDIATES AND METHODS OF USE THEREOF
#5618Method of initiating or escalating dofetilide dose and formulations therefor
#5619EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
#5620POLYION COMPLEX MICELLE THAT INCLUDES ANTISENSE OLIGONUCLEOTIDE AND BLOCK COPOLYMER OF PEG BLOCK AND CATIONIC POLYMER, SAID BLOCK COPOLYMER HAVING NUMBER-AVERAGE MOLECULAR WEIGHT OF 3-10 kDa
#5621BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION
#5622Injectable composition for preventing hair loss or stimulating hair growth
#5623METHODS FOR ADMINISTERING ARIPIPRAZOLE
#5624Multi-component injection
#5625METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE
#5626Treatment with anti-α4β7 antibody
#5627Affibody proteins specific for B7-H3 (CD276)
#5628Humanized antibodies with increased stability
#5629Materials and Methods for Treating Juvenile Idiopathic Arthritis
#5630PAN-ELR+ CXC chemokine antibodies for the treatment of hidradenitis suppurativa
#5631VEGF antagonist formulations suitable for intravitreal administration
#5632CD80 EXTRACELLULAR DOMAIN FC FUSION PROTEIN DOSING REGIMENS
#5633Compounds
#5634COMPOUNDS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION
#5635Compounds for the treatment of clostridium difficile infection
#5636Activators of the unfolded protein response
#5637METHODS FOR TREATING CANCEROUS TUMORS
#5638METHOD OF ADMINISTERING LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE
#5639Magnetic particle control and visualization
#5640INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
#5641COMPOSITIONS AND METHODS FOR MODIFIED DENDRIMER NANOPARTICLE DELIVERY
#5642BLADDER INJECTION PARADIGM FOR ADMINISTRATION OF BOTULINUM TOXINS
#5643STORAGE STABLE SOMATOSTATIN-DOPAMINE CHIMERIC COMPOUNDS AND SALT FORMS THEREOF
#5644AVEXITIDE FOR THE TREATMENT OF HYPERINSULINEMIC HYPOGLYCEMIA
#5645PRG-4 FOR TREATING GOUT AND ITS SYMPTOMS
#5646CELLS ENGINEERED FOR CO-EXPRESSION OF DECOY RECEPTOR 1 AND TNF-RELATED APOPTOSIS-INDUCING LIGAND AND USES THEREFOR
#5647NATURAL KILLER CELL COMPOSITIONS AND IMMUNOTHERAPY METHODS FOR TREATING TUMORS
#5648TREATMENT METHODS
#5649PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COVID-19
#5650HIGH CONCENTRATION FORMULATIONS
#5651Cytarabine conjugates for cancer therapy
#5652A teniposide injection with high dilution stability and preparation method thereof
#5653Pharmaceutical use of anemoside B4 against acute gouty arthritis
#5654Immunoablative therapies
#5655Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain
#5656CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD
#5657NIMODIPINE INJECTION COMPOSITION AND PREPARATION METHOD THEREFOR
#5658Use and method of L-aspartic acid beta-hydroxamate in preparing drugs for inhibiting choroidal neovascularization
#5659Compositions and methods for treating autism
#5660Inhibition of Acetyl-CoA Metabolism for Treatment and Prevention of Immune System Diseases and Disorders
#5661COMPOSITION FOR TREATMENT OF VITREOUS DISEASE OR DISORDER
#5662Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cell
#5663Method for preparing a composition with a low dissolved oxygen content, comprising acetaminophen, and optionally one or more NSAIDs, and a composition obtained thereof
#5664Intranasal pharmaceutical dosage forms comprising naloxone
#5665RADIATION SENSITIZER OR ANTI-CANCER CHEMOTHERAPY SENSITIZER
#5666NON-THERAPEUTIC METHOD, USES OF A SUBSTANCE THAT STIMULATES OR GENERATES AN INCREASE IN VOLUME
#5667EXTRACELLULAR VESICLES FOR TARGETED THERAPIES AGAINST MYELOID-DERIVED SUPPRESSOR CELLS
#5668GENE THERAPIES FOR LYSOSOMAL DISORDERS
#5669Adeno associated virus vectors for the treatment of hunter disease
#5670MINIATURIZED HAIRPIN RNAi TRIGGERS (mxRNA) AND METHODS OF USES THEREOF
#5671Codon optimized GLA genes and uses thereof
#5672Compositions for treatment of vascular disease
#5673TREATMENT OF HYPERTENSION BY RENAL VASCULAR DELIVERY OF GUANETHIDINE
#5674AAV vector for treatment of Friedreich's ataxia
#5675TREATMENT OF RETINAL DEGENERATION USING GENE THERAPY
#5676TREATMENT OF INFECTIONS
#5677LONG-ACTING POLYMERIC DELIVERY SYSTEMS
#5678Adjuvant treatment of HER2-positive breast cancer
#5679LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE
#5680Collagenase Clostridium Histolyticum injection therapies
#5681METHODS AND MATERIALS FOR TREATING OSTEOARTHRITIS
#5682Methods and compositions for inducing neural plasticity
#5683LACTATE-PROTECTED HYPOGLYCEMIA TO TREAT GLYCOLYSIS DEPENDENT PATHOLOGICAL CONDITIONS, IN PARTICULAR CANCER
#5684Semaglutide for use in medicine
#5685Children Blood Transfusion and Thymus Hormonal Therapy as Antiviral and Antibacterial Compounds
#5686Tetrathionate for cyanide and methylmercaptan poisoning
#5687CCR7 aptamers and uses thereof
#5688Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs
#5689PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#5690Compositions for the prevention and treatment of acute renal injury
#5691Method for treating cancer by combination of IAP inhibitor and modulator of immune checkpoint molecule
#5692Active ingredient consisting of a mixture of polylysine compounds and use in the prevention of strokes and the treatment of the post-stroke inflammatory phase
#5693Halogenated ether compounds and methods of inducing anesthesia
#5694COMPOSITIONS AND METHODS FOR ADMINISTERING ANESTHETICS
#5695AAV-based gene therapies for treatment of autoimmune diseases
#5696Methods and compositions for nucleic acid and protein payload delivery
#5697Cancer treatment
#5698DOSING
#5699ApoC-II mimetic peptides
#5700Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication